ICI 216140

bombesin-gastrin releasing peptide antagonist

Also Known As:

ICI-216140; N-isobutyryl-His-Trp-Ala-Val-Ala-His-Leu-NHMe; m 216140; m-216140; m216140; L-Leucinamide, N-(2-methyl-1-oxopropyl)-L-histidyl-L-tryptophyl-L-alanyl-L-valyl-D-alanyl-L-histidyl-N-methyl-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - ICI 216140: 1

Related Diseases

1.	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/01/1993 - "We examined the profile of two bombesin (BN) antagonists, (CH3)2CHCO-His-Trp-Ala-Val-D-Ala-His-Leu-NHCH3] (ICI 216140) and [D-Phe6,des-Met14]BN(6-14)ethylamide (DPDM-BN EA), against neuromedin B-induced Ca2+ mobilization in the small cell lung cancer (SCLC) line NCI-H345. "

Related Drugs and Biologics

1.	Bombesin
2.	Phe(6)-des-Met(14)- bombesin (6-14)-ethylamide
3.	alanylhistidine (Ala-His)
4.	neuromedin B